Srulijes, Karin http://orcid.org/0000-0002-4930-9821
Klenk, Jochen
Schwenk, Michael
Schatton, Cornelia
Schwickert, Lars
Teubner-Liepert, Kristin
Meyer, Miriam
K.C., Srijana
Maetzler, Walter
Becker, Clemens
Synofzik, Matthis
Funding for this research was provided by:
Robert Bosch Stiftung (32.5.1141.0049.0, .)
Article History
First Online: 8 January 2019
Compliance with Ethical Standards
: All patients provided written informed consent. The Ethics Committee of the University of Tübingen approved the study (application no. 602/2012BO1).
: The authors declare that they have no competing interests.
: Dr. Klenk, Dr. Srulijes, Mrs. Schatton, Mrs. Teubner-Liepert and Prof. Becker report no disclosures.Prof. Maetzler receives funding from the European Union, from the Michael J Fox Foundation, the Neuroalliance and Janssen. He received funding from the Robert Bosch foundation and speaker honoraria from GlaxoSmithKline, Rölke Pharma, Licher and UCB.Mr. Schwickert received consulting fees from Rölke Pharma.Dr. Synofzik received consulting fees from Actelion Pharmaceuticals Ltd.